Doxycycline Use During Breastfeeding
Short-term doxycycline use during lactation is considered compatible with breastfeeding in healthy term infants because milk levels are low and infant absorption is inhibited by calcium in human milk. [1]
Lactation Compatibility in Healthy Term Infants
Doxycycline use during breastfeeding is not likely to cause harm with short-term courses because milk doxycycline levels are low and absorption by the breastfeeding infant is inhibited by calcium in breastmilk. [1] Doxycycline milk levels have been measured in mothers nursing infants aged 15 to 30 days after administration of doxycycline 200 mg orally followed by 100 mg 12 hours later and after 100 mg daily dosing. [1]
Key Infant Precautions With Doxycycline
As a theoretical precaution, prolonged doxycycline use should be avoided during nursing because the main concern is tetracycline-related tooth and bone effects. [1] Infants should be monitored for rash and for possible effects on gastrointestinal flora, including diarrhea or candidiasis (thrush or diaper rash). [1]
Duration-Related Precautions (Theoretical Tetracycline Risks)
Courses up to 21 days are considered acceptable during nursing. [1] Prolonged use greater than 21 days or repeat courses during nursing should be avoided as a theoretical precaution. [1]
Precautions for Infants Younger Than 1 Month
Doxycycline has been studied in breastfeeding dyads with infants aged 15 to 30 days, supporting short-term compatibility in very young infants in healthy dyads. [1] The same precaution applies for infants under 1 month because the theoretical tetracycline concern is driven by duration and exposure rather than age alone. [1]
Precautions for Premature or Low Birth Weight Infants
Tetracycline antibiotics are associated with concerns for effects on tooth development and growth when used for long periods, including in premature infants. [2] Given the theoretical nature of risk and limited direct evidence in premature or low birth weight infants, prolonged doxycycline exposure should be avoided and infant monitoring for rash and gastrointestinal or candidiasis adverse effects should be performed. [1][2]
Monitoring During Maternal Therapy
Infant monitoring should include assessment for rash. [1] Infant monitoring should include assessment for diarrhea. [1] Infant monitoring should include assessment for candidiasis, including thrush and diaper rash. [1]
Practical Safety Boundaries
Alternative therapies should be considered when doxycycline exposure would be expected to exceed 21 days or require repeated courses. [1] Use of doxycycline is compatible with breastfeeding for short-term treatment courses in healthy, term infants, with monitoring and avoidance of prolonged or repeated exposure. [1]
References
[1] LactMed® (NCBI Bookshelf): Doxycycline, last revision May 15, 2024. [1] [2] FDA: Questions and Answers for Consumers on Doxycycline. [2]